Yıldırım Üşenmez T, Gültekin A, Erkan FM, Bayar BD, Can SY, Şanlı ME. The effect of mindfulness on medication adherence in individuals diagnosed with Schizophrenia: A cross-sectional study.
Perspect Psychiatr Care 2022;
58:2585-2591. [PMID:
35474214 DOI:
10.1111/ppc.13098]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/10/2022] [Revised: 04/07/2022] [Accepted: 04/10/2022] [Indexed: 11/30/2022] Open
Abstract
OBJECTIVE
The aim of this study is to determine the effect of mindfulness on medication adherence in individuals diagnosed with schizophrenia.
MATERIALS AND METHODS
This cross-sectional study was conducted with 147 individuals diagnosed with schizophrenia. The data were collected using the Descriptive Characteristics Form, Morisky Medication Adherence Scale, and Mindful Attention Awareness Scale.
RESULTS
A strong positive correlation was determined between the mindfulness level and medication adherence of the individuals diagnosed with schizophrenia. Furthermore, mindfulness of the individuals diagnosed with schizophrenia was statistically significant in explaining medication adherence (p < 0.05) and mindfulness predicted medication adherence by 64%.
CONCLUSION
It was observed that the individuals' mindfulness level was low and half of the participants had low medication adherence. Moreover, as their mindfulness level increased, so did their medication adherence.
Collapse